The Eastern Company
US ˙ NasdaqGM ˙ US2763171046

Introduction

This page provides a comprehensive analysis of the known insider trading history of Michael A Jr Mcmanus. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Michael A Jr Mcmanus has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:UAMY / United States Antimony Corporation Director 581,965
US:NVAX / Novavax, Inc. Director 10,101
US:EML / The Eastern Company Director 18,452
US:MSON / Misonix Inc President and CEO, Director 55,000
US:SHLM / Schulman (A.), Inc. Director 31,823
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Michael A Jr Mcmanus. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases EML / The Eastern Company - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in EML / The Eastern Company. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2017-05-19 EML MCMANUS MICHAEL A JR 5,000 25.9000 5,000 25.9000 129,500 17 31.3500 27,250 21.04

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

EML / The Eastern Company Insider Trades
Insider Sales EML / The Eastern Company - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in EML / The Eastern Company. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

EML / The Eastern Company Insider Trades
Insider Purchases NVAX / Novavax, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in EML / The Eastern Company. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2017-05-12 NVAX MCMANUS MICHAEL A JR 20,000 0.9698 1,000 19.3960 19,396 284 48.4 29,004 149.54
2017-05-11 NVAX MCMANUS MICHAEL A JR 10,000 0.8400 500 16.8000 8,400
2016-09-21 NVAX MCMANUS MICHAEL A JR 30,000 1.6099 1,500 32.1980 48,297
2005-09-01 NVAX MCMANUS MICHAEL A JR 20,000 1.6000 1,000 32.0000 32,000
2004-08-16 NVAX MCMANUS MICHAEL A JR 10,000 3.4100 500 68.2000 34,100

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

NVAX / Novavax, Inc. Insider Trades
Insider Sales NVAX / Novavax, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in EML / The Eastern Company. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2021-03-19 NVAX MCMANUS MICHAEL A JR 1,000 221.4000 1,000 221.4000 221,400 353 69.7300 -151,670 -68.50
2021-03-19 NVAX MCMANUS MICHAEL A JR 3,000 220.5700 3,000 220.5700 661,710
2020-08-18 NVAX MCMANUS MICHAEL A JR 8,000 146.0000 8,000 146.0000 1,168,000
2019-11-18 NVAX MCMANUS MICHAEL A JR 3,929 3.8215 3,929 3.8215 15,015

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

NVAX / Novavax, Inc. Insider Trades
Insider Purchases UAMY / United States Antimony Corporation - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in EML / The Eastern Company. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2024-12-10 UAMY MCMANUS MICHAEL A JR 70,000 1.4580 70,000 1.4580 102,060 259 4.9400 243,740 238.82
2024-11-18 UAMY MCMANUS MICHAEL A JR 50,000 0.5650 50,000 0.5650 28,250
2024-08-14 UAMY MCMANUS MICHAEL A JR 135,000 0.3830 135,000 0.3830 51,705

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

UAMY / United States Antimony Corporation Insider Trades
Insider Sales UAMY / United States Antimony Corporation - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in EML / The Eastern Company. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

UAMY / United States Antimony Corporation Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Michael A Jr Mcmanus as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-06-09 2025-05-27 4 UAMY UNITED STATES ANTIMONY CORP
Common Stock
A - Award 22,733 581,965 4.07
2024-12-11 2024-12-10 4 UAMY UNITED STATES ANTIMONY CORP
Common Stock
P - Purchase 70,000 338,333 26.09 1.46 102,060 493,290
2024-11-19 2024-11-18 4 UAMY UNITED STATES ANTIMONY CORP
Common Stock
P - Purchase 50,000 268,333 22.90 0.56 28,250 151,608
2024-08-15 2024-08-14 4 UAMY UNITED STATES ANTIMONY CORP
Common Stock
P - Purchase 135,000 218,333 162.00 0.38 51,705 83,622
2024-05-28 2024-03-01 4 UAMY UNITED STATES ANTIMONY CORP
Common Stock
A - Award 83,333 83,333
2022-06-21 2022-06-16 4 NVAX NOVAVAX INC
Common Stock
M - Exercise 700 10,101 7.45
2021-12-20 2021-12-17 4 EML EASTERN CO
Common Stock
A - Award 763 18,452 4.31 25.38 19,365 468,312
2021-09-20 2021-09-17 4 EML EASTERN CO
Common Stock
A - Award 796 17,689 4.71 24.98 19,884 441,871
2021-08-20 2021-06-25 4/A NVAX NOVAVAX INC
Restricted Stock Units
M - Exercise -3,450 3,450 -50.00
2021-08-20 2021-06-25 4/A NVAX NOVAVAX INC
Common Stock
M - Exercise 3,450 9,401 57.97
2021-06-29 2021-06-25 4 NVAX NOVAVAX INC
Restricted Stock Units
M - Exercise -6,900 0 -100.00
2021-06-29 2021-06-25 4 NVAX NOVAVAX INC
Common Stock
M - Exercise 6,900 12,851 115.95
2021-06-22 2021-06-17 4 NVAX NOVAVAX INC
Restricted Stock Units
A - Award 700 700
2021-06-22 2021-06-17 4 NVAX NOVAVAX INC
Stock Option (Right to Buy)
A - Award 1,300 1,300
2021-06-21 2021-06-17 4 EML EASTERN CO
Common Stock
A - Award 580 16,893 3.56 33.39 19,366 564,057
2021-03-30 2021-03-26 4 EML EASTERN CO
Common Stock
A - Award 732 16,313 4.70 26.49 19,391 432,131
2021-03-23 2021-03-19 4 NVAX NOVAVAX INC
Common Stock
S - Sale -3,000 5,951 -33.52 220.57 -661,710 1,312,612
2021-03-23 2021-03-19 4 NVAX NOVAVAX INC
Common Stock
S - Sale -1,000 8,951 -10.05 221.40 -221,400 1,981,751
2020-12-18 2020-12-16 4 EML EASTERN CO
Common Stock
A - Award 615 15,581 4.11 25.19 15,492 392,485
2020-09-30 2020-09-28 4 EML EASTERN CO
Common Stock
A - Award 890 14,966 6.32 22.33 19,874 334,191
2020-08-20 2020-08-18 4 NVAX NOVAVAX INC
Stock Option (Right to Buy)
M - Exercise -4,000 0 -100.00
2020-08-20 2020-08-18 4 NVAX NOVAVAX INC
Stock Option (Right to Buy)
M - Exercise -4,000 0 -100.00
2020-08-20 2020-08-18 4 NVAX NOVAVAX INC
Common Stock
S - Sale -8,000 9,951 -44.57 146.00 -1,168,000 1,452,846
2020-08-20 2020-08-18 4 NVAX NOVAVAX INC
Common Stock
M - Exercise 4,000 17,951 28.67 27.60 110,400 495,448
2020-08-20 2020-08-18 4 NVAX NOVAVAX INC
Common Stock
M - Exercise 4,000 17,951 28.67 27.60 110,400 495,448
2020-06-26 2020-06-25 4 NVAX NOVAVAX INC
Restricted Stock Units
A - Award 3,450 3,450
2020-06-26 2020-06-25 4 NVAX NOVAVAX INC
Stock Option (Right to buy)
A - Award 6,900 6,900
2020-06-18 2020-06-17 4 EML EASTERN CO
Common Stock
A - Award 1,059 14,076 8.14 18.29 19,369 257,450
2020-03-30 2020-03-26 4 EML EASTERN CO
Common Stock
A - Award 778 13,017 6.36 25.57 19,893 332,845
2019-12-23 2019-12-20 4 EML EASTERN CO
Common Stock
A - Award 390 12,239 3.29 29.79 11,618 364,600
2019-12-16 2019-12-12 4 NVAX NOVAVAX INC
Stock Option (Right to buy)
A - Award 18,000 18,000
2019-11-20 2019-11-18 4 NVAX NOVAVAX INC
Common Stock
S - Sale -3,929 9,951 -28.31 3.82 -15,015 38,028
2019-09-26 2019-09-24 4 EML EASTERN CO
Common Stock
A - Award 415 11,849 3.63 26.78 11,114 317,316
2019-06-25 2019-06-24 4 EML EASTERN CO
Common Stock
A - Award 404 11,434 3.66 26.30 10,625 300,714
2019-03-22 2019-03-22 4 EML EASTERN CO
Common Stock
A - Award 365 11,030 3.42 29.16 10,643 321,635
2018-12-26 2018-12-21 4 EML EASTERN CO
Common Stock
A - Award 425 10,665 4.15 23.24 9,877 247,855
2018-12-14 2018-12-13 4 NVAX NOVAVAX INC
Stock Option (Right to buy)
A - Award 90,000 90,000
2018-09-28 2018-09-27 4 EML EASTERN CO
Common Stock
A - Award 347 10,240 3.51 28.40 9,855 290,816
2018-06-21 2018-06-21 4 EML EASTERN CO
Common Stock
A - Award 355 9,893 3.72 30.70 10,898 303,715
2018-03-22 2018-03-21 4 EML EASTERN CO
Common Stock
A - Award 322 9,538 3.49 29.10 9,370 277,556
2017-12-22 2017-12-21 4 EML EASTERN CO
Common Stock
A - Award 335 9,216 3.77 27.95 9,363 257,587
2017-12-19 2017-12-15 4 NVAX NOVAVAX INC
Stock Option (Right to buy)
A - Award 80,000 80,000
2017-09-22 2017-09-21 4 EML EASTERN CO
Common Stock
A - Award 352 8,881 4.13 26.30 9,258 233,570
2017-06-23 2017-06-21 4 EML EASTERN CO
Common Stock
A - Award 247 8,529 2.98 30.30 7,484 258,429
2017-05-23 2017-05-19 4 EML EASTERN CO
Common Stock
P - Purchase 5,000 8,282 152.35 25.90 129,500 214,504
2017-05-12 2017-05-12 4 NVAX NOVAVAX INC
Common Stock
P - Purchase 20,000 277,590 7.76 0.97 19,396 269,207
2017-05-11 2017-05-11 4 NVAX NOVAVAX INC
Common Stock
P - Purchase 10,000 257,590 4.04 0.84 8,400 216,376
2017-03-27 2017-03-24 4 EML EASTERN CO
Common Stock
A - Award 427 3,282 14.96 19.45 8,305 63,835
2017-03-20 2017-03-16 4 NVAX NOVAVAX INC
Stock Option (Right to buy)
A - Award 80,000 80,000
2016-12-21 2016-12-20 4 EML EASTERN CO
Common Stock
A - Award 362 2,855 14.52 20.70 7,493 59,098
2016-09-28 2016-09-26 4 EML EASTERN CO
Common Stock
A - Award 385 2,493 18.26 19.53 7,519 48,688
2016-09-22 2016-09-21 4 NVAX NOVAVAX INC
Common Stock
P - Purchase 30,000 247,590 13.79 1.61 48,297 398,595
2016-07-01 2016-06-30 4 MSON MISONIX INC
Stock Option (right to buy)
M - Exercise -20,000 55,000 -26.67
2016-07-01 2016-06-30 4 MSON MISONIX INC
Common Stock, par value $.01
P - Purchase 20,000 371,017 5.70 1.91 38,200 708,642
2016-06-29 2016-06-27 4 EML EASTERN CO
Common Stock
A - Award 462 2,108 28.07 16.20 7,484 34,150
2016-04-04 2016-04-01 4 EML EASTERN CO
Common Stock
A - Award 619 1,646 60.27 16.00 9,904 26,336
2016-03-17 2016-03-15 4 NVAX NOVAVAX INC
Stock Option (Right to buy)
A - Award 40,000 40,000
2016-01-15 2016-01-13 4 SHLM SCHULMAN A INC
Common Stock
A - Award 2,736 31,823 9.41
2015-12-22 2015-12-22 4 EML EASTERN CO
Common Stock
A - Award 440 1,027 74.96 17.05 7,502 17,510
2015-09-30 2015-09-29 4 EML EASTERN CO
Common Stock
A - Award 458 587 355.04 16.39 7,507 9,621
2015-08-21 2015-08-19 4 NVAX NOVAVAX INC
Stock Option (Right to buy)
M - Exercise -30,000 0 -100.00
2015-08-21 2015-08-19 4 NVAX NOVAVAX INC
Stock Option (Right to buy)
M - Exercise -20,000 0 -100.00
2015-08-21 2015-08-19 4 NVAX NOVAVAX INC
Common Stock
M - Exercise 30,000 217,590 15.99 1.83 54,900 398,190
2015-08-21 2015-08-19 4 NVAX NOVAVAX INC
Common Stock
M - Exercise 20,000 187,590 11.93 2.50 50,000 468,975
2015-08-20 2015-08-19 4 MSON MISONIX INC
Stock Option (right to buy)
A - Award 50,000 50,000
2015-07-02 2015-07-01 4 EML EASTERN CO
Common Stock
A - Award 129 129 19.26 2,485 2,485
2015-05-28 3 EML EASTERN CO
Common Shares
0
2015-05-26 2015-05-22 4 MSON MISONIX INC
Stock Option (right to buy)
A - Award 100,000 100,000
2015-03-09 2015-03-05 4 NVAX NOVAVAX INC
Stock Option (Right to buy)
A - Award 40,000 40,000
2015-03-09 2014-06-17 4 NVAX NOVAVAX INC
Stock Option (Right to buy)
M - Exercise -30,000 0 -100.00
2015-03-09 2014-06-17 4 NVAX NOVAVAX INC
Stock Option (Right to buy)
M - Exercise -15,000 0 -100.00
2015-03-09 2014-06-17 4 NVAX NOVAVAX INC
Common Stock
M - Exercise 30,000 167,590 21.80 1.28 38,400 214,515
2015-03-09 2014-06-17 4 NVAX NOVAVAX INC
Common Stock
M - Exercise 15,000 137,590 12.24 0.56 8,400 77,050
2015-02-24 2015-02-20 4 NVAX NOVAVAX INC
Stock Option (Right to buy)
M - Exercise -15,000 0 -100.00
2015-02-24 2015-02-20 4 NVAX NOVAVAX INC
Stock Option (Right to buy)
M - Exercise -15,000 0 -100.00
2015-02-24 2015-02-20 4 NVAX NOVAVAX INC
Stock Option (Right to buy)
M - Exercise -15,000 0 -100.00
2015-02-24 2015-02-20 4 NVAX NOVAVAX INC
Common Stock
M - Exercise 15,000 122,590 13.94 2.35 35,250 288,086
2015-02-24 2015-02-20 4 NVAX NOVAVAX INC
Common Stock
M - Exercise 15,000 107,590 16.20 2.61 39,150 280,810
2015-02-24 2015-02-20 4 NVAX NOVAVAX INC
Common Stock
M - Exercise 15,000 92,590 19.33 1.48 22,200 137,033
2015-02-19 2015-02-17 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -100 363,636 -0.03 13.04 -1,304 4,741,813
2015-02-19 2015-02-17 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -100 363,736 -0.03 13.05 -1,305 4,746,755
2015-02-19 2015-02-17 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -100 363,836 -0.03 13.06 -1,306 4,751,698
2015-02-19 2015-02-17 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -100 363,936 -0.03 13.07 -1,307 4,756,644
2015-02-19 2015-02-17 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -200 364,036 -0.05 13.06 -2,611 4,752,490
2015-02-19 2015-02-17 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -400 364,236 -0.11 13.09 -5,236 4,767,849
2015-02-19 2015-02-17 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -500 364,636 -0.14 13.11 -6,555 4,780,378
2015-02-19 2015-02-17 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -200 365,136 -0.05 13.10 -2,619 4,781,456
2015-02-19 2015-02-17 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -200 365,336 -0.05 13.10 -2,621 4,787,728
2015-02-19 2015-02-17 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -481 365,536 -0.13 13.25 -6,373 4,843,352
2015-02-19 2015-02-18 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -409 351,017 -0.12 12.51 -5,117 4,391,223
2015-02-19 2015-02-18 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -850 351,426 -0.24 12.52 -10,642 4,399,854
2015-02-19 2015-02-18 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -6,198 352,276 -1.73 12.55 -77,785 4,421,064
2015-02-19 2015-02-18 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -800 358,474 -0.22 12.58 -10,064 4,509,603
2015-02-19 2015-02-18 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -240 359,274 -0.07 12.66 -3,038 4,548,409
2015-02-19 2015-02-18 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -200 359,514 -0.06 12.72 -2,544 4,573,018
2015-02-19 2015-02-18 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -700 359,714 -0.19 12.69 -8,883 4,564,771
2015-02-19 2015-02-18 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -322 360,414 -0.09 12.56 -4,044 4,526,800
2015-02-19 2015-02-18 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -100 360,736 -0.03 12.57 -1,257 4,534,452
2015-02-19 2015-02-18 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -200 360,836 -0.06 12.60 -2,520 4,546,534
2015-02-19 2015-02-18 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -100 361,036 -0.03 12.59 -1,259 4,545,443
2015-02-19 2015-02-18 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -200 361,136 -0.06 12.65 -2,530 4,568,370
2015-02-19 2015-02-18 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -200 361,336 -0.06 12.75 -2,550 4,607,034
2015-02-19 2015-02-18 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -100 361,536 -0.03 12.78 -1,278 4,620,430
2015-02-19 2015-02-18 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -537 361,636 -0.15 12.79 -6,868 4,625,324
2015-02-19 2015-02-18 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -100 362,173 -0.03 12.80 -1,280 4,635,814
2015-02-19 2015-02-18 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -100 362,273 -0.03 12.82 -1,282 4,644,340
2015-02-19 2015-02-18 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -100 362,373 -0.03 12.93 -1,293 4,685,483
2015-02-19 2015-02-18 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -230 362,473 -0.06 13.03 -2,997 4,723,023
2015-02-19 2015-02-18 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -307 362,703 -0.08 13.22 -4,059 4,794,934
2015-02-19 2015-02-18 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -201 363,010 -0.06 13.07 -2,627 4,744,541
2015-02-19 2015-02-18 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -425 363,211 -0.12 13.08 -5,559 4,750,800
2015-01-13 2015-01-09 4 SHLM SCHULMAN A INC
Common Stock
A - Award 2,090 29,087 7.74
2014-11-14 2014-11-13 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -6,818 366,017 -1.83 12.00 -81,816 4,392,204
2014-11-14 2014-11-13 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -100 372,835 -0.03 12.01 -1,201 4,477,748
2014-11-14 2014-11-13 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -400 372,935 -0.11 12.04 -4,816 4,490,137
2014-11-14 2014-11-13 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -100 373,335 -0.03 12.04 -1,204 4,496,820
2014-11-14 2014-11-13 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -300 373,435 -0.08 12.05 -3,615 4,499,892
2014-11-14 2014-11-13 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -112 373,735 -0.03 12.06 -1,351 4,507,244
2014-11-14 2014-11-13 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -100 373,847 -0.03 12.08 -1,208 4,516,072
2014-11-14 2014-11-13 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -100 373,947 -0.03 12.10 -1,210 4,522,889
2014-11-14 2014-11-13 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -100 374,047 -0.03 12.09 -1,209 4,522,228
2014-11-14 2014-11-13 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -1,400 374,147 -0.37 12.14 -16,996 4,542,145
2014-11-14 2014-11-13 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -100 375,547 -0.03 12.16 -1,216 4,564,774
2014-11-14 2014-11-13 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -100 375,647 -0.03 12.16 -1,216 4,567,868
2014-11-14 2014-11-13 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -100 375,747 -0.03 12.17 -1,217 4,572,841
2014-11-14 2014-11-13 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -100 375,847 -0.03 12.19 -1,219 4,581,575
2014-11-14 2014-11-13 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -300 375,947 -0.08 12.20 -3,660 4,586,553
2014-11-14 2014-11-13 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -200 376,247 -0.05 12.21 -2,442 4,593,976
2014-11-14 2014-11-13 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -100 376,447 -0.03 12.22 -1,222 4,600,182
2014-11-14 2014-11-13 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -100 376,547 -0.03 12.23 -1,223 4,605,170
2014-11-14 2014-11-12 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -2,770 376,647 -0.73 12.00 -33,240 4,519,764
2014-11-14 2014-11-12 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -810 379,417 -0.21 12.01 -9,728 4,556,798
2014-11-14 2014-11-12 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -100 380,227 -0.03 12.02 -1,202 4,568,427
2014-11-14 2014-11-12 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -200 380,327 -0.05 12.02 -2,404 4,571,531
2014-11-14 2014-11-12 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -100 380,527 -0.03 12.02 -1,202 4,575,837
2014-11-14 2014-11-12 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -51 380,627 -0.01 12.03 -614 4,578,943
2014-11-14 2014-11-12 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -300 380,678 -0.08 12.04 -3,612 4,583,363
2014-11-14 2014-11-12 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -58 380,978 -0.02 12.06 -699 4,594,595
2014-11-14 2014-11-12 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -100 381,036 -0.03 12.07 -1,207 4,599,105
2014-11-14 2014-11-12 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -523 381,136 -0.14 12.11 -6,334 4,615,557
2014-11-14 2014-11-12 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -52 381,659 -0.01 12.12 -630 4,625,707
2014-11-14 2014-11-12 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -10 381,711 0.00 12.13 -121 4,630,154
2014-11-14 2014-11-12 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -210 381,721 -0.05 12.15 -2,552 4,637,910
2014-11-14 2014-11-12 4 MSON MISONIX INC
Common Stock, par value $.01
S - Sale -5 381,931 0.00 12.22 -61 4,667,197
2014-09-17 2014-09-15 4 MSON MISONIX INC
Stock Option (right to buy)
M - Exercise -95,000 0 -100.00
2014-09-17 2014-09-15 4 MSON MISONIX INC
Stock Option (right to buy)
M - Exercise -30,000 0 -100.00
2014-09-17 2014-09-15 4 MSON MISONIX INC
Common Stock, par value $.01
F - Taxes -54,617 381,936 -12.51 9.01 -492,099 3,441,243
2014-09-17 2014-09-15 4 MSON MISONIX INC
Common Stock, par value $.01
M - Exercise 95,000 436,553 27.81 5.18 492,100 2,261,345
2014-09-17 2014-09-15 4 MSON MISONIX INC
Common Stock, par value $.01
F - Taxes -17,248 341,553 -4.81 9.01 -155,404 3,077,393
2014-09-17 2014-09-15 4 MSON MISONIX INC
Common Stock, par value $.01
M - Exercise 30,000 358,801 9.12 5.18 155,400 1,858,589
2014-09-11 2014-09-09 4 MSON MISONIX INC
Stock Option (right to buy)
A - Award 125,000 125,000
2014-05-13 2014-05-12 4 MSON MISONIX INC
Stock Option (right to buy)
M - Exercise -25,000 75,000 -25.00
2014-05-13 2014-05-12 4 MSON MISONIX INC
Common Stock, par value $.01
P - Purchase 25,000 328,801 8.23 1.82 45,500 598,418
2014-03-07 2014-03-06 4 NVAX NOVAVAX INC
Stock Option (Right to buy)
A - Award 30,000 225,000 15.38
2014-02-21 2014-02-20 4 MSON MISONIX INC
Stock Option (right to buy)
M - Exercise -25,000 75,000 -25.00
2014-02-21 2014-02-20 4 MSON MISONIX INC
Common Stock, par value $.01
P - Purchase 25,000 303,801 8.97 1.91 47,750 580,260
2014-01-15 2014-01-13 4 SHLM SCHULMAN A INC
Common Stock
A - Award 2,315 26,997 9.38
2013-09-12 2013-09-10 4 MSON MISONIX INC
Stock Option (right to buy)
A - Award 125,000 125,000
2013-03-06 2013-03-02 4 NVAX NOVAVAX INC
Options-right to buy
A - Award 30,000 237,500 14.46 1.83 54,900 434,625
2013-02-13 2013-02-12 4 MSON MISONIX INC
Stock Option (right to buy)
M - Exercise -10,000 115,000 -8.00
2013-02-13 2013-02-12 4 MSON MISONIX INC
Common Stock, par value $.01
P - Purchase 10,000 278,801 3.72 4.66 46,600 1,299,213
2013-01-14 2013-01-10 4 SHLM SCHULMAN A INC
Common Stock
A - Award 2,786 24,682 12.72
2012-12-07 2012-12-05 4 MSON MISONIX INC
Stock Option (right to buy)
A - Award 6,300 6,300
2012-11-27 2012-11-26 4 MSON MISONIX INC
Common Stock, par value $.01
P - Purchase 20,000 268,801 8.04 4.10 82,000 1,102,084
2012-09-13 2012-09-11 4 MSON MISONIX INC
Stock Option (right to buy)
A - Award 118,700 118,700
2012-04-11 2012-04-09 4 SHLM SCHULMAN A INC
Restricted Stock Units
M - Exercise -2,500 0 -100.00
2012-04-11 2012-04-09 4 SHLM SCHULMAN A INC
Common Stock
M - Exercise 2,500 21,896 12.89
2012-03-08 2012-03-01 4 NVAX NOVAVAX INC
Options-right to buy
A - Award 20,000 197,500 11.27 1.28 25,600 252,800
2012-01-17 2012-01-12 4/A SHLM SCHULMAN A INC
Common Stock
A - Award 3,730 19,396 23.81
2012-01-12 2012-01-12 4 SHLM SCHULMAN A INC
Common Stock
A - Award 3,500 19,166 22.34
2008-03-10 2008-03-06 4 nvax NOVAVAX INC
Option - right to buy
A - Award 15,000 15,000
2007-03-09 2007-03-07 4 nvax NOVAVAX INC
Option - right to buy
A - Award 15,000 15,000
2006-12-18 3 SHLM SCHULMAN A INC
No securities owned
0
2006-02-22 2006-02-17 4 NVAX NOVAVAX INC
Option
A - Award 15,000 15,000 4.60 69,000 69,000
2005-09-09 2005-09-01 4/A NVAX NOVAVAX INC
Common Stock ($.01 par value)
P - Purchase 20,000 60,000 50.00 1.60 32,000 96,000
2005-09-02 2005-09-01 4 NVAX NOVAVAX INC
Common Stock ($.01 par value)
A - Award 20,000 60,000 50.00 1.60 32,000 96,000
2005-05-06 2005-05-04 4 NVAX NOVAVAX INC
Option (1)
A - Award 15,000 40,000 60.00 1.48 22,200 59,200
2004-08-18 2004-08-16 4 NVAX NOVAVAX INC
Common Stock ($.01 par value)
P - Purchase 10,000 40,000 33.33 3.41 34,100 136,400
2004-03-15 2004-03-09 4 NVAX NOVAVAX INC
Right-To-Buy
A - Award 20,000 102,500 24.24
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)